Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Journal of Medicinal Chemistry|October 19, 2022
BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical ProbeJudith Günther, Roman C Hillig, Katja Zimmermann, et al.Neurology(R) Neuroimmunology & Neuroinflammation|November 22, 2022
More Efficient Complement Activation by Anti-Aquaporin-4 Compared With Anti-Myelin Oligodendrocyte Glycoprotein AntibodiesMagdalena Lerch, Kathrin Schanda, Eliott Lafon, et al.European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|November 9, 2020
E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disordersArlette L Bruijstens, Christian Lechner, Lorraine Flet-Berliac, et al.Multiple Sclerosis and Related Disorders|August 7, 2022
MR imaging in children with transverse myelitis and acquired demyelinating syndromesInes El Naggar, Robert Cleaveland, Eva-Maria Wendel, et al.Neurology(R) Neuroimmunology & Neuroinflammation|August 18, 2025
A20 (TNFAIP3) Distinguishes Attack From Remission in Pediatric Patients With Monophasic MOGADChristian Lechner, Shrishti Saxena, Hrishikesh A Lokhande, et al.Neurology(R) Neuroimmunology & Neuroinflammation|May 3, 2020
Clinical and imaging features of children with autoimmune encephalitis and MOG antibodiesAndreas Wegener-Panzer, Robert Cleaveland, Eva-Maria Wendel, et al.Journal of Neurology|February 10, 2018
MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoproteinMatthias Baumann, Astrid Grams, Tanja Djurdjevic, et al.European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|November 12, 2020
E.U. paediatric MOG consortium consensus: Part 5 - Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disordersArlette L Bruijstens, Eva-Maria Wendel, Christian Lechner, et al.Journal of Medicinal Chemistry|October 26, 2021
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2ALars Wortmann, Nico Bräuer, Simon J Holton, et al.Journal of Medicinal Chemistry|December 20, 2018
Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2- d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5Duy Nguyen, Clara Lemos, Lars Wortmann, et al.Pageof 5